Qaseem A, Usman N, Jayaraj JS, Janapala RN, Kashif T (2019) Cancer of unknown primary: a review on clinical guidelines in the development and targeted management of patients with the unknown primary site. Cureus 11(9):e5552

PubMed  PubMed Central  Google Scholar 

Civantos FJ, Vermorken JB, Shah JP, Rinaldo A, Suárez C, Kowalski LP et al (2020) Metastatic squamous cell carcinoma to the cervical lymph nodes from an unknown primary Cancer: management in the HPV era. Front Oncol 10:593164

Article  PubMed  PubMed Central  Google Scholar 

Golusinski P, Di Maio P, Pehlivan B, Colley S, Nankivell P, Kong A et al (2019) Evidence for the approach to the diagnostic evaluation of squamous cell carcinoma occult primary tumors of the head and neck. Oral Oncol 88:145–152

Article  PubMed  Google Scholar 

Galloway TJ, Ridge JA (2015) Management of squamous Cancer metastatic to cervical nodes with an unknown primary site. J Clin Oncol off J Am Soc Clin Oncol 33(29):3328–3337

Article  CAS  Google Scholar 

Strojan P, Ferlito A, Medina JE, Woolgar JA, Rinaldo A, Robbins KT et al (2013) Contemporary management of lymph node metastases from an unknown primary to the neck: I. A review of diagnostic approaches. Head Neck 35(1):123–132

Article  PubMed  Google Scholar 

Calabrese L, Jereczek-Fossa BA, Jassem J, Rocca A, Bruschini R, Orecchia R et al (2005) Diagnosis and management of neck metastases from an unknown primary. Acta Otorhinolaryngol Ital Organo Uff Della Soc Ital Otorinolaringol E Chir Cerv-facc 25(1):2–12

CAS  Google Scholar 

Bauwens L, Baltres A, Fiani DJ, Zrounba P, Buiret G, Fleury B et al (2021) Prevalence and distribution of cervical lymph node metastases in HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma. Radiother Oncol J Eur Soc Ther Radiol Oncol 157:122–129

Article  Google Scholar 

Issing WJ, Taleban B, Tauber S (2003) Diagnosis and management of carcinoma of unknown primary in the head and neck. Eur Arch Oto-Rhino-Laryngol off J Eur Fed Oto-Rhino-Laryngol soc EUFOS Affil Ger soc Oto-Rhino-Laryngol -. Head Neck Surg 260(8):436–443

Google Scholar 

Saghatchian M, Fizazi K, Borel C, Ducreux M, Rufflé P, Le Chevalier T et al (2001) Carcinoma of an unknown primary site: a chemotherapy strategy based on histological differentiation – results of a prospective study. Ann Oncol 12(4):535–540

Article  CAS  PubMed  Google Scholar 

Briasoulis E, Tolis C, Bergh J, Pavlidis N, ESMO Guidelines Task Force (2005) ESMO Minimum Clinical recommendations for diagnosis, treatment and follow-up of cancers of unknown primary site (CUP). Ann Oncol off J Eur Soc Med Oncol 16(Suppl 1):i75–76

Article  Google Scholar 

COSMIC database. Mutational Signatures (v2 - March 2015) [Internet]. Available from: https://cancer.sanger.ac.uk/signatures/signatures_v2/

Brash DE (2015) UV signature mutations. Photochem Photobiol 91(1):15–26

Article  CAS  PubMed  Google Scholar 

Berg RJ, van Kranen HJ, Rebel HG, de Vries A, van Vloten WA, Van Kreijl CF et al (1996) Early p53 alterations in mouse skin carcinogenesis by UVB radiation: immunohistochemical detection of mutant p53 protein in clusters of preneoplastic epidermal cells. Proc Natl Acad Sci U S A 93(1):274–278

Article  CAS  PubMed  PubMed Central  ADS  Google Scholar 

Chan JW, Yeh I, El-Sayed IH, Algazi AP, Glastonbury CM, Ha PK et al (2019) Ultraviolet light-related DNA damage mutation signature distinguishes cutaneous from mucosal or other origin for head and neck squamous cell carcinoma of unknown primary site. Head Neck 41(6):E82–E85

Article  PubMed  Google Scholar 

Boyle TA, Mondal AK, Saeed-Vafa D, Ananth S, Ahluwalia P, Kothapalli R et al (2021) Guideline-Adherent Clinical Validation of a comprehensive 170-Gene DNA/RNA panel for determination of small variants, Copy Number variations, Splice Variants, and fusions on a next-generation sequencing platform in the CLIA setting. Front Genet 12:503830

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li MM, Datto M, Duncavage EJ, Kulkarni S, Lindeman NI, Roy S et al (2017) Standards and guidelines for the interpretation and reporting of sequence variants in Cancer: a Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists. J Mol Diagn JMD 19(1):4–23

Article  CAS  PubMed  Google Scholar 

Lewis JS, Beadle B, Bishop JA, Chernock RD, Colasacco C, Lacchetti C et al (2018) Human papillomavirus testing in Head and Neck carcinomas: Guideline from the College of American Pathologists. Arch Pathol Lab Med 142(5):559–597

Article  PubMed  Google Scholar 

López F, Rodrigo JP, Silver CE, Haigentz M, Bishop JA, Strojan P et al (2016) Cervical lymph node metastases from remote primary tumor sites: Cervical Lymph Node Metastases from a Non-Head and Neck Primary. Eisele D, editor. Head Neck. 38(S1):E2374–85

Alexandrov LB, Kim J, Haradhvala NJ, Huang MN, Tian Ng AW, Wu Y et al (2020) The repertoire of mutational signatures in human cancer. Nature 578(7793):94–101

Article  CAS  PubMed  PubMed Central  ADS  Google Scholar 

Alexandrov LB, Nik-Zainal S, Wedge DC, Aparicio SAJR, Behjati S, Biankin AV et al (2013) Signatures of mutational processes in human cancer. Nature 500(7463):415–421

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nik-Zainal S, Alexandrov LB, Wedge DC, Van Loo P, Greenman CD, Raine K et al (2012) Mutational processes molding the genomes of 21 breast cancers. Cell 149(5):979–993

Article  CAS  PubMed  PubMed Central  Google Scholar 

Helleday T, Eshtad S, Nik-Zainal S (2014) Mechanisms underlying mutational signatures in human cancers. Nat Rev Genet 15(9):585–598

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lawrence CW (1981) Are pyrimidine dimers non-instructive lesions? Mol Gen Genet MGG 182(3):511–513

Article  CAS  PubMed  Google Scholar 

Miller JH (1985) Mutagenic specificity of ultraviolet light. J Mol Biol 182(1):45–65

Article  CAS  PubMed  ADS  Google Scholar 

Drobetsky EA, Grosovsky AJ, Glickman BW (1987) The specificity of UV-induced mutations at an endogenous locus in mammalian cells. Proc Natl Acad Sci U S A 84(24):9103–9107

Article  CAS  PubMed  PubMed Central  ADS  Google Scholar 

Wikonkal NM, Brash DE (1999) Ultraviolet radiation induced signature mutations in photocarcinogenesis. J Investig Dermatol Symp Proc 4(1):6–10

Schwaederle M, Elkin SK, Tomson BN, Carter JL, Kurzrock R, Squamousness (2015) Next-generation sequencing reveals shared molecular features across squamous tumor types. Cell Cycle 14(14):2355–2361

Article  CAS  PubMed  PubMed Central  Google Scholar 

King AD, Deirawan H, Klein PA, Dasgeb B, Dumur CI, Mehregan DR (2023) Next-generation sequencing in dermatology. Front Med (Lausanne) 10:1218404

Article  PubMed  Google Scholar 

Chung CH, Guthrie VB, Masica DL, Tokheim C, Kang H, Richmon J, Agrawal N, Fakhry C, Quon H, Subramaniam RM, Zuo Z, Seiwert T, Chalmers ZR, Frampton GM, Ali SM, Yelensky R, Stephens PJ, Miller VA, Karchin R, Bishop JA (2015) Genomic alterations in head and neck squamous cell carcinoma determined by cancer gene-targeted sequencing. Ann Oncol 26(6):1216–1223

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cancer Genome Atlas Network (2015) Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature 517(7536):576–582

Article  ADS  Google Scholar 

McDowell LJ, Young RJ, Johnston ML, Tan TJ, Kleid S, Liu CS et al (2016) p16-positive lymph node metastases from cutaneous head and neck squamous cell carcinoma: no association with high-risk human papillomavirus or prognosis and implications for the workup of the unknown primary. Cancer 122(8):1201–1208

Article  CAS  PubMed  Google Scholar 

Satgunaseelan L, Chia N, Suh H, Virk S, Ashford B, Lum T et al (2017) p16 expression in cutaneous squamous cell carcinoma of the head and neck is not associated with integration of high risk HPV DNA or prognosis. Pathol (Phila) 49(5):494–498

CAS  Google Scholar 

Stephen JK, Divine G, Chen KM, Chitale D, Havard S, Worsham MJ (2013) Significance of p16 in site-specific HPV positive and HPV negative head and Neck squamous cell carcinoma. Cancer Clin Oncol 2(1):51–61

PubMed  Google Scholar 

Colebatch AJ, Di Stefano L, Wong SQ, Hannan RD, Waring PM, Dobrovic A et al (2016) Clustered somatic mutations are frequent in transcription factor binding motifs within proximal promoter regions in melanoma and other cutaneous malignancies. Oncotarget 7(41):66569–66585

Article  PubMed  PubMed Central  Google Scholar 

Sun L, Cliften PF, Duncavage EJ, Lewis JS, Chernock RD (2019) UV signature mutations reclassify salivary high-grade neuroendocrine carcinomas as Occult Metastatic Cutaneous Merkel Cell Carcinomas. Am J Surg Pathol 43(5):682–687

Article  PubMed  Google Scholar 

Wong SQ, Waldeck K, Vergara IA, Schröder J, Madore J, Wilmott JS et al (2015) UV-Associated mutations underlie the etiology of MCV-Negative Merkel Cell Carcinomas. Cancer Res 75(24):5228–5234

Article  CAS  PubMed  Google Scholar 

Fishbach S, Steinhardt G, Zhen CJ, Puranik R, Segal JP, Cipriani NA (2022) High rates of Ultraviolet-signature mutations in squamous cell carcinomas of the parotid gland and prognostic implications. Head Neck Pathol 16(1):236–247

Article  PubMed  Google Scholar 

Hartsough E, Mino-Kenudson M, Lennerz JK, Dias-Santagata D, Hoang MP (2023) Clinical next-generation sequencing panels reveal molecular differences between Merkel Cell Polyomavirus-Negative Merkel Cell Carcinomas and Neuroendocrine Carcinomas. Am J Clin Pathol 159(4):395–406

Article  CAS  PubMed  Google Scholar